When the dollar is strong, a U.S.-based company that sells products overseas earns fewer dollars. On the flip side, the cost of imported goods and foreign expenses are lower.
IBJ Podcast: Jeff Simmons on Elanco’s global HQ and creating a magnet for talent, innovation
CEO Jeff Simmons explains why the project is far more than simply an office building. He tells host Mason King that the goal is to create what the company calls “a post-COVID workplace destination” that attracts talent to the city and the company and gives workers more flexibility and engagement.Read More
Elanco unveils plans for new ‘epicenter of animal health innovation’
Elanco Animal Health Inc. on Tuesday broke ground and shared new designs for its planned $100 million-plus global headquarters at the former General Motors Stamping Plant site just west of downtown Indianapolis.Read More
Elanco, High Alpha Innovation launch ag-tech startup Athian
The startup, Athian, aims to help farmers and ranchers measure, and eventually monetize, their efforts to reduce the carbon footprint of their cattle operations.Read More
Elanco cuts 380 positions, including about 20% of senior management
Elanco said the cuts, which include three executive vice presidents, were an effort in “streamlining and simplifying organizational structure,” and were intended to increase productivity and reduce organizational complexity.Read More
The Greenfield-based company will lay out the design for its $100 million-plus global headquarters in Indianapolis on Thursday before a hearing examiner, who will rule on the project.
U.S. District Court Judge Sarah Evans Barker ruled the plaintiffs failed to clearly show that public statements made by Elanco’s top officials were false and misleading during a two-year period in question.
BiomEdit, one of Indiana’s newest life-science companies, said Monday it will locate its headquarters in Fishers, but hinted it could eventually move to the new $100 million Elanco Animal Health headquarters campus now under construction in Indianapolis.
Several analysts said Elanco faces a bright future, implying that the market might be overreacting to the lowered revenue and profit guidance.
CEO Jeff Simmons’ goal is to make Indianapolis “an epicenter of animal health innovation.” While a bold goal, Simmons has proven he is a bold leader who prioritizes the growth of his company, as well as the community.
Elanco Animal Health Inc. said Thursday morning that revenue climbed 46% last year and its net loss narrowed, strengthening its financial position as it prepares to break ground this spring on a new $100 million headquarters in Indianapolis.
Elanco Animal Health Inc. officials say they expect to break ground on the company’s new $100 million headquarters just west of downtown Indianapolis in early 2022 after fine-tuning plans for the project with city and state officials.
Greenfield-based Elanco Animal Health Inc. disclosed on Monday that it received a subpoena from the U.S. Securities and Exchange Commission on July 1 related to its channel inventory and sales practices prior to mid-2020.
Shares of the Greenfield-based maker of animal feeds and vaccines dove after the firm warned that it’s facing inflationary pressures, increased logistics costs and other headwinds.
The project was given a final, and unanimous, approval by the city’s Metropolitan Development Commission—the last step necessary to allow the city to request the funds from the Indianapolis Bond Bank.
The tax-increment financing bonds will be used to pave the way for Elanco Animal Health Inc. to build its new headquarters on the former General Motors stamping plant property west of downtown.
The deal would boost Greenfield-based Elanco’s profile in the billion-dollar pet dermatology market and continue its acquisition strategy.
It was the best quarter yet for Elanco since its spinoff from former parent Eli Lilly and Co. in 2018.
The maker of animal feeds and vaccines also is closing research and development sites in Germany and New Zealand, and making smaller cuts elsewhere. Altogether, Elanco is chopping 350 jobs in 23 countries.
Officials said remediation efforts are in their final stages, with final certification expected in the next few weeks. Elanco Animal Health Inc. plans to build a $100 million headquarters on the site.
The state’s pitch to keep Elanco Animal Health Inc. in Indiana for the long term began with a dinner at the Governor’s Residence two years ago.
Elanco Animal Health Inc.’s announcement Friday that it will move its headquarters to Indianapolis came as a surprise to many business leaders in Greenfield. While disappointed, they say they are hopeful the move won’t be a significant blow to the city’s economy.
Beyond the public company’s $100 million headquarters campus, city and state leaders expect 26 acres to be used for an expansion of White River State Park and new projects potentially with residential, retail and office uses.
The total doesn’t include the value of the land the state will give to Elanco Animal Health for the project. Even so, the combined city and state package is possibly the largest amount of tax breaks ever considered for an economic development deal in Indiana.